- 22139987OWN - NLMSTAT- MEDLINEDA  - 20111205DCOM- 20120306IS  - 0040-5930 (Print)IS  - 0040-5930 (Linking)VI  - 68IP  - 12DP  - 2011 DecTI  - [Advanced heart failure - treatment options beyond medical management].PG  - 715-23LID - 10.1024/0040-5930/a000235 [doi]AB  - Improvement of heart failure therapy has led to a far better survival and quality      of life of patients. Treatment of the underlying disease, patient education and      improvement of compliance and consequent upgrading of medical heart failure      therapy often delays further progression to an advanced stage of heart failure.      Nevertheless heart failure remains a chronic progressive disease and it is up to       the treating clinician to identify the signs of advanced heart failure in a      timely manner in order to evaluate patients for further treatment strategies such      as heart transplantation. This article should help define advanced heart failure       and illustrate how patients are evaluated for further therapy. Outcome of heart      transplantation or mechanically assisted circulatory support is strongly      associated to proper patient selection and timing.FAU - Martinelli, Michele VAU  - Martinelli MVAD  - Schweizer Herz- und Gefasszentrum, Universitatsklinik fur Kardiologie,      Inselspital, Bern. michele.martinelli@insel.chFAU - Bosch, ClaudiaAU  - Bosch CFAU - Signorell, JankoAU  - Signorell JFAU - Mohacsi, PaulAU  - Mohacsi PLA  - gerPT  - English AbstractPT  - Journal ArticlePT  - ReviewTT  - Chronische Herzinsuffizienz im fortgeschrittenen Stadium - konservativ      medikamentose Therapie, Kunstherz- oder Herztransplantation?PL  - SwitzerlandTA  - Ther UmschJT  - Therapeutische Umschau. Revue therapeutiqueJID - 0407224RN  - 0 (Cardiovascular Agents)SB  - IMMH  - Age FactorsMH  - Cardiovascular Agents/*therapeutic useMH  - Combined Modality TherapyMH  - Disease ProgressionMH  - Eligibility Determination/methodsMH  - Heart Failure/classification/diagnosis/mortality/*therapyMH  - *Heart Transplantation/contraindications/mortalityMH  - *Heart, ArtificialMH  - Heart-Assist DevicesMH  - HumansMH  - Patient ComplianceMH  - Patient Education as TopicMH  - Patient SelectionMH  - PrognosisMH  - Prosthesis DesignMH  - Risk FactorsMH  - SwitzerlandMH  - Waiting ListsEDAT- 2011/12/06 06:00MHDA- 2012/03/07 06:00CRDT- 2011/12/06 06:00AID - 10.1024/0040-5930/a000235 [doi]PST - ppublishSO  - Ther Umsch. 2011 Dec;68(12):715-23. doi: 10.1024/0040-5930/a000235.- 22139987own - nlmstat- medlineda  - 20111205dcom- 20120306is  - 0040-5930 (print)is  - 0040-5930 (linking)vi  - 68ip  - 12dp  - 2011 decti  - [advanced heart failure - treatment options beyond medical management].pg  - 715-23lid - 10.1024/0040-5930/a000235 [doi]ab  - improvement of heart failure therapy has led to a far better survival and quality      of life of patients. treatment of the underlying disease, patient education and      improvement of compliance and consequent upgrading of medical heart failure      therapy often delays further progression to an advanced stage of heart failure.      nevertheless heart failure remains a chronic progressive disease and it is up to       the treating clinician to identify the signs of advanced heart failure in a      timely manner in order to evaluate patients for further treatment strategies such      as heart transplantation. this article should help define advanced heart failure       and illustrate how patients are evaluated for further therapy. outcome of heart      transplantation or mechanically assisted circulatory support is strongly      associated to proper patient selection and timing.fau - martinelli, michele vau  - martinelli mvad  - schweizer herz- und gefasszentrum, universitatsklinik fur kardiologie,      inselspital, bern. michele.martinelli@insel.chfau - bosch, claudiaau  - bosch cfau - signorell, jankoau  - signorell jfau - mohacsi, paulau  - mohacsi pla  - gerpt  - english abstractpt  - journal articlept  - reviewtt  - chronische herzinsuffizienz im fortgeschrittenen stadium - konservativ      medikamentose therapie, kunstherz- oder herztransplantation?pl  - switzerlandta  - ther umschjt  - therapeutische umschau. revue therapeutiquejid - 0407224rn  - 0 (cardiovascular agents)sb  - immh  - age factorsmh  - cardiovascular agents/*therapeutic usemh  - combined modality therapymh  - disease progressionmh  - eligibility determination/methodsmh  - heart failure/classification/diagnosis/mortality/*therapymh  - *heart transplantation/contraindications/mortalitymh  - *heart, artificialmh  - heart-assist devicesmh  - humansmh  - patient compliancemh  - patient education as topicmh  - patient selectionmh  - prognosismh  - prosthesis designmh  - risk factorsmh  - switzerlandmh  - waiting listsedat- 2011/12/06 06:00mhda- 2012/03/07 06:00crdt- 2011/12/06 06:00aid - 10.1024/0040-5930/a000235 [doi]pst - ppublishso  - ther umsch. 2011 dec;68(12):715-23. doi: 10.1024/0040-5930/a000235.